$7.45
-0.03-0.40%
al cierre: -
$7.45
N/A
After hour: Nov 7, 4:00 PM EDT
Bioventus emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/04/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.57 | $560.00M | $570.00M | $566.83M | |
08/06/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.66 | $560.00M | $570.00M | $565.82M | |
05/06/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.66 | $560.00M | $570.00M | $564.86M | |
03/11/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.55 | $560.00M | $570.00M | $554.78M | |
11/05/2024 | BVS | Bioventus | FY | 2024 | $0.40 | $0.42 | $0.39 | $562.00M | $567.00M | $561.77M | |
08/06/2024 | BVS | Bioventus | FY | 2024 | $0.36 | $0.42 | $0.28 | $557.00M | $567.00M | $542.77M | |
05/07/2024 | BVS | Bioventus | FY | 2024 | $0.25 | $0.33 | $0.16 | $535.00M | $550.00M | $528.03M | |
03/12/2024 | BVS | Bioventus | FY | 2024 | $0.12 | $0.20 | $0.33 | $520.00M | $535.00M | $517.82M | |
11/07/2023 | BVS | Bioventus | FY | 2023 | -$0.12 | -$0.09 | -$0.19 | $498.00M | $505.00M | $499.79M | |
08/08/2023 | BVS | Bioventus | FY | 2023 | -$0.24 | -$0.20 | -$0.22 | $490.00M | $505.00M | $493.14M | |
11/21/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.26 | $517.00M | $522.00M | $530.25M | |
11/08/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.51 | $527.00M | $532.00M | $553.86M | |
08/11/2022 | BVS | Bioventus | FY | 2022 | $0.47 | $0.57 | $0.65 | $547.50M | $562.50M | $552.13M | |
05/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | |
05/03/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | |
04/26/2022 | BVS | Bioventus | Q1 | 2022 | — | — | — | $116.50M | $118.50M | $117.76M | |
03/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $558.52M | |
01/11/2022 | BVS | Bioventus | Q4 | 2021 | — | — | — | $128.50M | $131.50M | $124.56M | |
01/11/2022 | BVS | Bioventus | FY | 2021 | — | — | — | $429.00M | $432.00M | $429.33M |
La orientación más reciente para Bioventus (BVS) se informó el noviembre 4, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $0.64 a $0.68, en comparación con el EPS estimado de $0.57. Además, Bioventus pronosticó ingresos entre $0.56B y $0.57B para el trimestre.
Explora orientación y previsión sobre todos los valores.